Russell Advert
Pelgar old banner
Brandenburg

Company Profile…ICB Pharma – Formulating innovative physical solutions for global pest management

| February 21, 2016

icb-logoICB Pharma is a Polish company that has been dealing with protecting people and animals against biological threats, as well as providing agrochemical solutions in agricultural situations and in plant cultivation.

The company is a continuation of a long-lasting family tradition that was initiated by Professor Wojchiech Alojz Świętosławski who was, inter alia, Professor at the University of Warsaw, Warsaw University of Technology and Mellon Institute of Industrial Research in Pittsburgh. He is considered to be one of the fathers of modern thermochemistry and he introduced and implemented the first international physicochemical standard – benzoic acid. This substance, according to the International Union of Pure and Applied Chemistry’s decision, was then regarded as a calorimetric standard, and which was later changed, also at Professor Świętosławski’s request, to hydrogen. He was also a double Nobel Prize nominee.

“Creative work is based on the ability of perceiving of what is unseen or passed by the others”

A favourite aphorism of Wojciech Świetosławski (1881 – 1968). Considered to be the father of modern thermochemistry he was Vice-Chairman of the International Union of Pure and Applied Chemistry (IUPAC).

His outstanding scientific achievements have been continued by following generations. His grandson, Dr Janusz Świetosławski inherited some of his skills and passion for chemistry and together with Janusz’s own two sons, Tomasz and Paweł, they today collectively own and manage ICB Pharma.

Continuing a long family tradition in innovative chemistry, the owners of ICB at the recent opening of their new facility, Dr Janusz Świetosławski (right) together with his two sons, Tomasz (centre) and Paweł (left)

Continuing a long family tradition in innovative chemistry, the owners of ICB at the recent opening of their new facility, Dr Janusz Świetosławski (right) together with his two sons, Tomasz (centre) and Paweł (left)

Since the very beginning, the company has been founded on the thorough knowledge and passion of its creators, as well as on the reliability of its research. As time has passed, the ICB Pharma logo has become recognisable all over the world and is associated with innovation and exceeding the previously established standards.

The company’s products are associated with safe use, care of natural environment as well as innovation and high standards of quality.

The opening of new premises in 2015 was a landmark in the history of ICB Pharma and created a new expressive space for the R&D department. The impressive building consists of production facilities, analytical and biological laboratories, as well as office space. The management are sure that this investment will result in a faster and more dynamic development of the company. It also can be considered to be a capstone for all the hard work, plans and ambition of ICB Pharma’s owners, in creating a modern chemical company.

The new premises are also significant for the local community, as many new employees can be found within the company that now provides opportunities for following professional careers and fulfilling ambitions. A strong organization and coordination of work practices together with the smooth flow of interdepartmental information are key elements for optimizing the company’s functionality. The adoption of modern solutions and sophisticated IT tools has resulted in a highly effective company system.

Drawing on staff from the local community, many new employees can be found within ICB Pharma where they can obtain many new opportunities for following professional careers and fulfilling ambitions.

Drawing on staff from the local community, many new employees can be found within ICB Pharma where they can obtain many new opportunities for following professional careers and fulfilling ambitions.

The foundation and driving force of ICB Pharma is the R&D Department. Employing the specialists; highly educated and experienced chemists and biologists, led by Dr Janusz Świetoslawski. The R&D department has undertaken the greatest challenges for many years, and has played an undeniably crucial role in developing the area of pharmaceuticals, sanitary hygiene and agro-chemistry. The best innovative examples are the achievements in developing the technology of microencapsulating active ingredients, in which respect, ICB Pharma can be considered among the most advanced of chemical companies.

The company is divided into three main departments, namely: Health Care, Pest Innovations and Crop Solutions.

The formulations prepared by Health Care department provide examples of how the effective use of new technologies can solve some popular health problems.

Products in the range of Allergoff are designed to protect people who are allergic to dust mites. Long–term protection is provided for sensitive individuals, using trace amounts of substances in polymer capsules. When applied, the House Dust Mite is immobilized through the creation of an active barrier or film which also neutralizes the allergen-containing faecal droppings. The aggregation of the latter also helps to facilitate vacuum cleaning.The aggregated faecal droppings cannotfloat in the air thus providing a reductionin the risk of their pulmonary aspiration.A single application provides a long-term(up to 6 months) reduction and neutralization of the allergen-containing faecal droppings.

Another example of an unconventional way of solving health problems is the formulation devoted to eliminating ectoparasites. A method of physically removing anthropods has been created to overcome some of the problems of pesticide methods. In humans, the product,Nitolic, even at a low dose, has proven to be 100% effective without the need of arepeat applications. It controls all active developmental stages of the head lice,even eggs and makes combing to remove the lice easier.

The Pest Innovations department wasthe first, and for quite a long time, the onlydepartment of ICB Pharma. Created at the end of the 1990’s, it has led innovation in the market of Pest Control, developing products based on double-wall microencapsulation. Among these is Dergall,designed to control infestations of the RedPoultry mite (Dermanyssus gallinae) and other parasitic arthropods of medical andveterinary importance.

The great majority of products providesolutions for modern bio-risk management. The technologies are a hybrid of biochemistry, biotechnology, biology and chemical technology. The possibilities offered by such technology as micro- and nano-encapsulation has led to the creation of products that might help in elimination of serious diseases, such as malaria and Lyme disease transmission by insects. Due to technology and passion, ICB Pharma has for the process of product creation, its solutions have become appreciated worldwide – in Asia, the USA, South and Latin America, Africa and in Europe.

The relatively youngest department, Crop Solutions deals with developing innovative solution for crop protection. This department has announced its first successes with its lead product, Siltac. This contains a unique combination of silicone polymeric compounds. After dilution in water and spraying onto infested plants it spreads quickly on treated surface and creates a three-dimensional polymeric, grid structure (breathable film). The resulting structure covers the pests very tightly and immobilizes them, eventually leading to their death. The product is recognized not just in Poland, but is also now being introduced in many other countries. A wide array of other projects and solutions are being prepared. These include plant protection products, plant growth stimulators, and adjuvants.

Production facilities have been created to manufacture pharmaceuticals, biocides and agrochemical substances. The equipment and machinery can manufacture many different formulations, with rigorous standards of production to protect against cross contamination.

Production facilities have been created to manufacture pharmaceuticals, biocides and agrochemical substances. The equipment and machinery can manufacture many different formulations, with rigorous standards of production to protect against cross contamination.

Production facilities have been created to manufacture pharmaceuticals, biocides and agrochemical substances. The equipment and machinery can manufacture many different formulations, including sophisticated microencapsulated products and oil dispersions, with rigorous standards of production to protect against cross contamination. This allows simultaneous, clean and safe formulating processes with different substances.

Finished products as well as raw materials are thoroughly and precisely controlled at many levels by our physiochemical analysis laboratory. Such standards of production processes are the reason ICB is regarded as a reliable supplier as well as business partner.

The analytical laboratory is not only the place where internal controls take place as the company follows the standards that meet the requirements of Good Laboratory Practices (GLP). The standards of analytical work on pesticides and other chemical products provides ICB Pharma with the possibility of offering this as a service to other companies.

ICB group

ICB pharma is a credible business partner, supplying technologies and formulations all over the world based on innovative development and the highest quality standards.

For more information visit : www.icbpharma.pl

caption: Drawing on staff from the local community, many new employees can be found within ICB Pharma where they can obtain many new opportunities for following professional careers and fulfilling ambitions.

Published in International Pest Control – January/February 2016 issue.

Tags: , , , ,

Category: Company news, Company Profile

Frowein 728x90
IPC60yr